Concepedia

Tuba Ozbay

TO

Statistics

Publications

8

Citations

403

H-Index

8

Active since

2004

Affiliations

Emory University(Current)

Cancer Institute (WIA)

Winship Cancer Institute

Georgia Institute of Technology

Tuba Ozbay is an author at Emory University specializing in molecular oncology, oncology, and cancer cell signaling.

Publications per year

2004–2011

8

Publications

8

Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines

Tuba Ozbay, Rita Nahta · Breast Cancer Basic and Clinical Research · 2011 · 77 citations · Full text

Medicine, Oncology, Pharmacology +12

Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens

Rita Nahta, Sylvia Shabaya, Tuba Ozbay et al. · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · 2009 · 59 citations

Medicine, Oncology, Pharmacology +17

Modulation of the BRCA1 Protein and Induction of Apoptosis in Triple Negative Breast Cancer Cell Lines by the Polyphenolic Compound Curcumin

Danica L. Rowe, Tuba Ozbay, Ruth O’Regan et al. · Breast Cancer Basic and Clinical Research · 2009 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Cyclic Adenosine 5′-Monophosphate-Dependent Sphingosine-1-Phosphate Biosynthesis Induces Human CYP17 Gene Transcription by Activating Cleavage of Sterol Regulatory Element Binding Protein 1

Tuba Ozbay, Anne Rowan, Adam Leon et al. · Endocrinology · 2005 · 54 citations

Life Sciences, Biochemistry, Endocrinology +17

Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer

Danica L. Rowe, Tuba Ozbay, Laura M. Bender et al. · Molecular Cancer Therapeutics · 2008 · 48 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 8